The Gross Margin of Helix BioPharma Corp (HBP.TO) is 63.80%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-07-31 | 63.80% |